Studies have shown that ALDOB-mediated fructose metabolism drives metabolic reprogramming of liver metastases from colon cancer; loss of ALDOB activates insulin receptor(IR) signaling primarily through releasing IR/ALDOB interaction to promote de novo lipogenesis and hepatocellular carcinoma [42, 43]. Here, ALDOB is linked to colonic neoplasm.